BLOOD-BRAIN BARRIER FOR L-DOPA IN HYPOTHALAMUS

[1] EFFECTS OF L-DOPA IN TREATMENT OF PARKINSONIAN AKINESIA [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1967, 92 (11) : 483 - +

[2] AXELROD J, 1962, J BIOL CHEM, V237, P1657

[3] INCREASE OF CEREBRAL CATECHOLAMINES CAUSED BY 3,4-DIHYDROXYPHENYLALANINE AFTER INHIBITION OF PERIPHERAL DECARBOXYLASE [J]. NATURE, 1967, 215 (5103) : 852 - +

[4] VERTEILUNG DES 5-HYDROXYTRYPTAMINS (SEROTONIN) IM GEHIRN DES MENSCHEN UND SEIN VERHALTEN BEI PATIENTEN MIT PARKINSON-SYNDROM [J]. KLINISCHE WOCHENSCHRIFT, 1961, 39 (20): : 1056 - +

[5] BERTLER A, 1963, ACTA PHARMACOL TOX, V20, P317

[6] BERTLER A, 1966, PHARMACOL REV, V18, P369

[7] BIRKMAYER W, 1961, Wien Klin Wochenschr, V73, P787

[8] THE DISTRIBUTION OF SEROTONIN, 5-HYDROXYTRYPTOPHAN DECARBOXYLASE, AND MONOAMINE OXIDASE IN BRAIN [J]. JOURNAL OF NEUROCHEMISTRY, 1957, 1 (03) : 272 - 278

[9] CARLSSON A, 1966, PHARMACOL REV, V18, P541

[10] CAPILLARY BARRIER FOR DOPA IN BRAIN AND DIFFERENT ORGANS [J]. PSYCHOPHARMACOLOGIA, 1969, 15 (02): : 75 - &

[1] EFFECTS OF L-DOPA IN TREATMENT OF PARKINSONIAN AKINESIA [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1967, 92 (11) : 483 - +

[2] AXELROD J, 1962, J BIOL CHEM, V237, P1657

[3] INCREASE OF CEREBRAL CATECHOLAMINES CAUSED BY 3,4-DIHYDROXYPHENYLALANINE AFTER INHIBITION OF PERIPHERAL DECARBOXYLASE [J]. NATURE, 1967, 215 (5103) : 852 - +

[4] VERTEILUNG DES 5-HYDROXYTRYPTAMINS (SEROTONIN) IM GEHIRN DES MENSCHEN UND SEIN VERHALTEN BEI PATIENTEN MIT PARKINSON-SYNDROM [J]. KLINISCHE WOCHENSCHRIFT, 1961, 39 (20): : 1056 - +

[5] BERTLER A, 1963, ACTA PHARMACOL TOX, V20, P317

[6] BERTLER A, 1966, PHARMACOL REV, V18, P369

[7] BIRKMAYER W, 1961, Wien Klin Wochenschr, V73, P787

[8] THE DISTRIBUTION OF SEROTONIN, 5-HYDROXYTRYPTOPHAN DECARBOXYLASE, AND MONOAMINE OXIDASE IN BRAIN [J]. JOURNAL OF NEUROCHEMISTRY, 1957, 1 (03) : 272 - 278

[9] CARLSSON A, 1966, PHARMACOL REV, V18, P541

[10] CAPILLARY BARRIER FOR DOPA IN BRAIN AND DIFFERENT ORGANS [J]. PSYCHOPHARMACOLOGIA, 1969, 15 (02): : 75 - &